<DOC>
	<DOCNO>NCT00758251</DOCNO>
	<brief_summary>The purpose study assess severity illness schizophrenia patient routine clinical practice time entry study treatment Seroquel XR 8 week . PLEASE NOTE : Seroquel SR Seroquel XR refer formulation . The SR designation change XR consultation FDA .</brief_summary>
	<brief_title>Observation Change Clinical Global Impression Scores Schizophrenia Patients Receiving Seroquel XR Treatment</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Adult patient Schizophrenia prescribe Seroquel XR accord approve product information inclusion noninterventional study Signed date Patient Informed Consent ( ICF ) Hypersensitivity active substance excipients Seroquel XR</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>Seroquel XR</keyword>
	<keyword>CGI</keyword>
</DOC>